JP2024534952A - 卵巣老化、卵巣疾患および状態、ならびにその症状を処置するための組成物および方法 - Google Patents

卵巣老化、卵巣疾患および状態、ならびにその症状を処置するための組成物および方法 Download PDF

Info

Publication number
JP2024534952A
JP2024534952A JP2024515109A JP2024515109A JP2024534952A JP 2024534952 A JP2024534952 A JP 2024534952A JP 2024515109 A JP2024515109 A JP 2024515109A JP 2024515109 A JP2024515109 A JP 2024515109A JP 2024534952 A JP2024534952 A JP 2024534952A
Authority
JP
Japan
Prior art keywords
extract
subject
compound
acid
pharma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024515109A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534952A5 (https=
Inventor
ケシャフ ケー． シン，
Original Assignee
ユバ バイオサイエンシーズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユバ バイオサイエンシーズ， インコーポレイテッド filed Critical ユバ バイオサイエンシーズ， インコーポレイテッド
Publication of JP2024534952A publication Critical patent/JP2024534952A/ja
Publication of JP2024534952A5 publication Critical patent/JP2024534952A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2024515109A 2021-09-07 2022-09-07 卵巣老化、卵巣疾患および状態、ならびにその症状を処置するための組成物および方法 Pending JP2024534952A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163241429P 2021-09-07 2021-09-07
US63/241,429 2021-09-07
PCT/US2022/042799 WO2023038999A1 (en) 2021-09-07 2022-09-07 Compositions and methods for treating ovarian aging, ovarian diseases and conditions, and symptoms thereof

Publications (2)

Publication Number Publication Date
JP2024534952A true JP2024534952A (ja) 2024-09-26
JP2024534952A5 JP2024534952A5 (https=) 2026-04-24

Family

ID=85506938

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515109A Pending JP2024534952A (ja) 2021-09-07 2022-09-07 卵巣老化、卵巣疾患および状態、ならびにその症状を処置するための組成物および方法

Country Status (4)

Country Link
US (1) US20250017992A1 (https=)
EP (1) EP4398921A4 (https=)
JP (1) JP2024534952A (https=)
WO (1) WO2023038999A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116798634B (zh) * 2023-08-25 2023-11-21 北京大学深圳医院 一种fsh启动剂量预测系统、电子设备及存储介质
CN119112879A (zh) * 2024-09-26 2024-12-13 郑州大学第一附属医院 尿石素a在制备延缓卵巢衰老药物或保健食品中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU782286B2 (en) * 1999-06-30 2005-07-14 Advanced Cell Technology, Inc. Cytoplasmic transfer to de-differentiate recipient cells
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US20070027107A1 (en) * 2005-07-29 2007-02-01 Curt Hendrix Compositions and methods for treating estrogen-dependent diseases and conditions
US20070065396A1 (en) * 2005-09-21 2007-03-22 Tracie Martyn International, Llc Topical macqui berry formulation
US8212076B2 (en) * 2006-08-04 2012-07-03 Covalence, Inc. Prevention of cellular senescence in mammals by natural peptide complexes
WO2009066712A1 (ja) * 2007-11-21 2009-05-28 Kracie Pharma, Ltd. アロマターゼ阻害剤
US10967019B2 (en) * 2015-11-30 2021-04-06 Taiwan Mitochondrion Applied Technology Co., Ltd. Method for protecting mitochondria in retina cell
TWI728079B (zh) * 2017-03-24 2021-05-21 台灣粒線體應用技術股份有限公司 餘甘子萃取物用於製備提升粒線體功能以對抗老化之組合物的用途
US20200054682A1 (en) * 2018-08-14 2020-02-20 Imel Biotherapeutics, Inc. Methods and compositions for treating mitochondrial disease or disorders and heteroplasmy

Also Published As

Publication number Publication date
WO2023038999A1 (en) 2023-03-16
US20250017992A1 (en) 2025-01-16
EP4398921A4 (en) 2025-08-27
EP4398921A1 (en) 2024-07-17

Similar Documents

Publication Publication Date Title
US20240189218A1 (en) Compositions and methods for improving mitochondrial function
RU2491917C2 (ru) Наноэмульсия
Chen et al. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery
Wolf et al. Influences of opioids and nanoparticles on in vitro wound healing models
CN104755075B (zh) 非那雄胺和米诺地尔聚合物纳米粒子、其制备方法、药物组合物及其用途
KR102127527B1 (ko) 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도
TWI257303B (en) A method for enhancing protective cellular responses to genotoxic stress in skin
US20230149493A1 (en) Compositions and methods for treating covid-19 and symptoms thereof
JP6058263B2 (ja) 癌細胞においてアポトーシスを誘導する方法および使用
JP2024534952A (ja) 卵巣老化、卵巣疾患および状態、ならびにその症状を処置するための組成物および方法
CN105168008A (zh) 抗皱用组合物和皮肤外用组合物
JP5685315B2 (ja) ニコチン酸アデニンディヌクレオチドリン酸又はその誘導体を含む薬学又は化粧料組成物
Souto et al. Lipid nanocarriers for hyperproliferative skin diseases
ES2689070T3 (es) Composición farmacéutica tópica, método para producir la composición farmacéutica tópica, uso de la composición farmacéutica tópica y método para el tratamiento tópico de psoriasis, dermatitis atópica o eczema crónico
JP5106446B2 (ja) Ｕｖケア用組成物
CN115400129A (zh) 细胞衰老表型改变用或皮肤老化防止用组合物
AU2021242332A1 (en) Compositions and methods relating to pigmentation
HK40102196A (zh) 用於改善线粒体功能的组合物和方法
AU2022357284A1 (en) Brightening compositions and methods of use
CN112004516A (zh) 皮肤屏障功能异常的改善用组合物
CN107614060A (zh) 皮肤状况的治疗
WO2025064867A1 (en) Delivery system for mitochondrial health enhancers
JP2020125285A (ja) 神経変性性障害の治療方法
CN115531404B (zh) 具有抗紫外辐射功效的皮肤外用组合物及其用途
JPWO2010137335A1 (ja) α−リポ酸ナノ粒子を含有する、ターンオーバー促進用組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250908

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250908

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260416